Skip to content
ppharmaranks
Menu
Class IIOngoing

Progesterone Injection USP recall

FDA recall D-0186-2025 · initiated Dec 27, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jan 15, 2025How we research

Eugia US LLC recalled Progesterone Injection USP in Dec 2024 — an FDA Class II recall (D-0186-2025) because Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.

Something got into the product

A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Batch # 1PR24010, Expiry: 02/28/2027

Quantity recalled: 17,300 10-mL vials

Details

Product
Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10
Recalling company
Eugia Pharma
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Distributed Nationwide in the USA.
Initiated
Dec 27, 2024
FDA report date
Jan 15, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Progesterone Injection USP recalled?
Eugia US LLC recalled Progesterone Injection USP in Dec 2024 — an FDA Class II recall (D-0186-2025) because Presence of Particulate Matter: A market complaint was received of a glass piece in the vial. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Progesterone Injection USP recalled?
Per the FDA enforcement record, the reason for recall D-0186-2025 was: Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
Is a recalled Progesterone Injection USP dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Progesterone Injection USP are affected?
Distributed: Distributed Nationwide in the USA.. The recall covers these lots — Batch # 1PR24010, Expiry: 02/28/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0186-2025.

Source: openFDA Drug Enforcement record D-0186-2025

← All drug recalls